Latest papers

The effect of nebivolol treatment on oxidative stress and antioxidant status in patients with cardiac syndrome-X.

[Studies on chemical constituents of root of Millettia speciosa]

New drug update: 2008.

[Dracorhodin perchlorate inhibit high glucose-induced connective tissue growth factor formation in human mesangial cells]

Trifluoroacetic acid-mediated facile transformation of 2-C-hydroxymethyl-D-glycals to chiral pyrano[2,3-b]benzopyrans.

Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.

Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model.

Complement-fixing activity of fulvic acid from Shilajit and other natural sources.

A novel (S)-(+)-decursin derivative, (S)-(+)-3-(3,4-dihydroxy-phenyl)-acrylic acid 2,2-dimethyl-8-oxo-3,4-dihydro-2H,8H-pyrano[3,2-g]chromen-3-yl-ester, inhibits ovalbumin-induced lung inflammation in a mouse model of asthma.

Aggregation of titanium dioxide nanoparticles: role of a fulvic acid.

Proton binding properties of humic substances originating from natural and contaminated materials.

Isolation and identification of precocenes and piperitone from essential oils as specific inhibitors of trichothecene production by Fusarium graminearum.

In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens.

KR-31761, a novel K+(ATP)-channel opener, exerts cardioprotective effects by opening both mitochondrial K+(ATP) and Sarcolemmal K+(ATP) channels in rat models of ischemia/reperfusion-induced heart injury.

Dopaminergic modulation of risk-based decision making.

Drug approvals: '08 in review. Nebivolol (Bystolic).

The use of microelectrode array (MEA) to study the protective effects of potassium channel openers on metabolically compromised HL-1 cardiomyocytes.

Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta.

Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.

Combining 3D-QSAR, docking, molecular dynamics and MM/PBSA methods to predict binding modes for nonsteroidal selective modulator to glucocorticoid receptor.